Home > > > > Report Detail

Global Recombinant Human Insulin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 26-Oct-2022
No. of pages: 102
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Recombinant Human Insulin manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Recombinant Human Insulin market. Further, it explains the major drivers and regional dynamics of the global Recombinant Human Insulin market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Akron Biotech

- Wockhardt

- Dance Biopharm

- Novo Nordisk

- Gan & Lee

- United Laboratories

- Dongbro Pharmaceuticri

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Recombinant Human Insulin Segment by Type

- by Recombinant DNA Technology Using Fermentation in Bacteria Way

- by Recombinant DNA Technology Using Fermentation in Yeast Way

Recombinant Human Insulin Segment by Application

- Type 1 Diabetes Mellitus

- Type 2 Diabetes Mellitus

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Recombinant Human Insulin market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Recombinant Human Insulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Recombinant Human Insulin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant Human Insulin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Human Insulin sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Recombinant Human Insulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Recombinant Human Insulin sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Akron Biotech, Wockhardt, Dance Biopharm, Novo Nordisk, Gan & Lee, United Laboratories and Dongbro Pharmaceuticri, etc.

Global Recombinant Human Insulin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Recombinant Human Insulin Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 by Recombinant DNA Technology Using Fermentation in Bacteria Way
1.2.3 by Recombinant DNA Technology Using Fermentation in Yeast Way
1.3 Market Segment by Application
1.3.1 Global Recombinant Human Insulin Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Type 1 Diabetes Mellitus
1.3.3 Type 2 Diabetes Mellitus
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Recombinant Human Insulin Market Size (2017-2028)
2.1.1 Global Recombinant Human Insulin Revenue (2017-2028)
2.1.2 Global Recombinant Human Insulin Sales (2017-2028)
2.2 Global Recombinant Human Insulin Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Recombinant Human Insulin Sales by Regions (2017-2022)
2.2.2 Global Recombinant Human Insulin Revenue by Regions (2017-2022)
2.3 Global Recombinant Human Insulin Market Size Forecast by Region
2.3.1 Global Recombinant Human Insulin Sales Forecast by Region (2023-2028)
2.3.2 Global Recombinant Human Insulin Revenue Forecast by Region (2023-2028)
2.4 Global Top Recombinant Human Insulin Regions (Countries) Ranking by Market Size
2.5 Recombinant Human Insulin Market Dynamics
2.5.1 Recombinant Human Insulin Market Trends
2.5.2 Recombinant Human Insulin Market Drivers
2.5.3 Recombinant Human Insulin Market Challenges
2.5.4 Recombinant Human Insulin Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Recombinant Human Insulin Manufacturers by Sales (2017-2022)
3.1.1 Global Recombinant Human Insulin Sales by Manufacturers (2017-2022)
3.1.2 Global Recombinant Human Insulin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Recombinant Human Insulin Sales in 2021
3.2 Global Top Manufacturers Recombinant Human Insulin by Revenue
3.2.1 Global Recombinant Human Insulin Revenue by Manufacturers (2017-2022)
3.2.2 Top Recombinant Human Insulin Manufacturers Covered: Ranking by Revenue
3.2.3 Global Recombinant Human Insulin Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Recombinant Human Insulin Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Human Insulin as of 2021)
3.4 Global Recombinant Human Insulin Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Recombinant Human Insulin Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Recombinant Human Insulin Market
3.7 Key Manufacturers Recombinant Human Insulin Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Recombinant Human Insulin Market Size by Type
4.1 Global Recombinant Human Insulin Historic Market Review by Type (2017-2022)
4.1.1 Global Recombinant Human Insulin Sales Market Share by Type (2017-2022)
4.1.2 Global Recombinant Human Insulin Revenue Market Share by Type (2017-2022)
4.1.3 Recombinant Human Insulin Price by Type (2017-2022)
4.2 Global Recombinant Human Insulin Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Recombinant Human Insulin Sales Forecast by Type (2023-2028)
4.2.2 Global Recombinant Human Insulin Revenue Forecast by Type (2023-2028)
4.2.3 Recombinant Human Insulin Price Forecast by Type (2023-2028)
5 Global Recombinant Human Insulin Market Size by Application
5.1 Global Recombinant Human Insulin Historic Market Review by Application (2017-2022)
5.1.1 Global Recombinant Human Insulin Sales Market Share by Application (2017-2022)
5.1.2 Global Recombinant Human Insulin Revenue Market Share by Application (2017-2022)
5.1.3 Recombinant Human Insulin Price by Application (2017-2022)
5.2 Global Recombinant Human Insulin Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Recombinant Human Insulin Sales Forecast by Application (2023-2028)
5.2.2 Global Recombinant Human Insulin Revenue Forecast by Application (2023-2028)
5.2.3 Recombinant Human Insulin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Recombinant Human Insulin Sales Breakdown by Company
6.1.1 North America Recombinant Human Insulin Sales by Company (2017-2022)
6.1.2 North America Recombinant Human Insulin Revenue by Company (2017-2022)
6.2 North America Recombinant Human Insulin Market Size by Type
6.2.1 North America Recombinant Human Insulin Sales by Type (2017-2028)
6.2.2 North America Recombinant Human Insulin Revenue by Type (2017-2028)
6.3 North America Recombinant Human Insulin Market Size by Application
6.3.1 North America Recombinant Human Insulin Sales by Application (2017-2028)
6.3.2 North America Recombinant Human Insulin Revenue by Application (2017-2028)
6.4 North America Recombinant Human Insulin Market Size by Country
6.4.1 North America Recombinant Human Insulin Sales by Country (2017-2028)
6.4.2 North America Recombinant Human Insulin Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Recombinant Human Insulin Sales Breakdown by Company
7.1.1 Europe Recombinant Human Insulin Sales by Company (2017-2022)
7.1.2 Europe Recombinant Human Insulin Revenue by Company (2017-2022)
7.2 Europe Recombinant Human Insulin Market Size by Type
7.2.1 Europe Recombinant Human Insulin Sales by Type (2017-2028)
7.2.2 Europe Recombinant Human Insulin Revenue by Type (2017-2028)
7.3 Europe Recombinant Human Insulin Market Size by Application
7.3.1 Europe Recombinant Human Insulin Sales by Application (2017-2028)
7.3.2 Europe Recombinant Human Insulin Revenue by Application (2017-2028)
7.4 Europe Recombinant Human Insulin Market Size by Country
7.4.1 Europe Recombinant Human Insulin Sales by Country (2017-2028)
7.4.2 Europe Recombinant Human Insulin Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Human Insulin Sales Breakdown by Company
8.1.1 Asia Pacific Recombinant Human Insulin Sales by Company (2017-2022)
8.1.2 Asia Pacific Recombinant Human Insulin Revenue by Company (2017-2022)
8.2 Asia Pacific Recombinant Human Insulin Market Size by Type
8.2.1 Asia Pacific Recombinant Human Insulin Sales by Type (2017-2028)
8.2.2 Asia Pacific Recombinant Human Insulin Revenue by Type (2017-2028)
8.3 Asia Pacific Recombinant Human Insulin Market Size by Application
8.3.1 Asia Pacific Recombinant Human Insulin Sales by Application (2017-2028)
8.3.2 Asia Pacific Recombinant Human Insulin Revenue by Application (2017-2028)
8.4 Asia Pacific Recombinant Human Insulin Market Size by Region
8.4.1 Asia Pacific Recombinant Human Insulin Sales by Region
8.4.2 Asia Pacific Recombinant Human Insulin Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Recombinant Human Insulin Sales Breakdown by Company
9.1.1 Latin America Recombinant Human Insulin Sales by Company (2017-2022)
9.1.2 Latin America Recombinant Human Insulin Revenue by Company (2017-2022)
9.2 Latin America Recombinant Human Insulin Market Size by Type
9.2.1 Latin America Recombinant Human Insulin Sales by Type (2017-2028)
9.2.2 Latin America Recombinant Human Insulin Revenue by Type (2017-2028)
9.3 Latin America Recombinant Human Insulin Market Size by Application
9.3.1 Latin America Recombinant Human Insulin Sales by Application (2017-2028)
9.3.2 Latin America Recombinant Human Insulin Revenue by Application (2017-2028)
9.4 Latin America Recombinant Human Insulin Market Size by Country
9.4.1 Latin America Recombinant Human Insulin Sales by Country (2017-2028)
9.4.2 Latin America Recombinant Human Insulin Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Human Insulin Sales Breakdown by Company
10.1.1 Middle East and Africa Recombinant Human Insulin Sales by Company (2017-2022)
10.1.2 Middle East and Africa Recombinant Human Insulin Revenue by Company (2017-2022)
10.2 Middle East and Africa Recombinant Human Insulin Market Size by Type
10.2.1 Middle East and Africa Recombinant Human Insulin Sales by Type (2017-2028)
10.2.2 Middle East and Africa Recombinant Human Insulin Revenue by Type (2017-2028)
10.3 Middle East and Africa Recombinant Human Insulin Market Size by Application
10.3.1 Middle East and Africa Recombinant Human Insulin Sales by Application (2017-2028)
10.3.2 Middle East and Africa Recombinant Human Insulin Revenue by Application (2017-2028)
10.4 Middle East and Africa Recombinant Human Insulin Market Size by Country
10.4.1 Middle East and Africa Recombinant Human Insulin Sales by Country (2017-2028)
10.4.2 Middle East and Africa Recombinant Human Insulin Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Akron Biotech
11.1.1 Akron Biotech Corporation Information
11.1.2 Akron Biotech Overview
11.1.3 Akron Biotech Recombinant Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Akron Biotech Recombinant Human Insulin Products and Services
11.1.5 Akron Biotech Recombinant Human Insulin SWOT Analysis
11.1.6 Akron Biotech Recent Developments
11.2 Wockhardt
11.2.1 Wockhardt Corporation Information
11.2.2 Wockhardt Overview
11.2.3 Wockhardt Recombinant Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Wockhardt Recombinant Human Insulin Products and Services
11.2.5 Wockhardt Recombinant Human Insulin SWOT Analysis
11.2.6 Wockhardt Recent Developments
11.3 Dance Biopharm
11.3.1 Dance Biopharm Corporation Information
11.3.2 Dance Biopharm Overview
11.3.3 Dance Biopharm Recombinant Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Dance Biopharm Recombinant Human Insulin Products and Services
11.3.5 Dance Biopharm Recombinant Human Insulin SWOT Analysis
11.3.6 Dance Biopharm Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Corporation Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Recombinant Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Novo Nordisk Recombinant Human Insulin Products and Services
11.4.5 Novo Nordisk Recombinant Human Insulin SWOT Analysis
11.4.6 Novo Nordisk Recent Developments
11.5 Gan & Lee
11.5.1 Gan & Lee Corporation Information
11.5.2 Gan & Lee Overview
11.5.3 Gan & Lee Recombinant Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Gan & Lee Recombinant Human Insulin Products and Services
11.5.5 Gan & Lee Recombinant Human Insulin SWOT Analysis
11.5.6 Gan & Lee Recent Developments
11.6 United Laboratories
11.6.1 United Laboratories Corporation Information
11.6.2 United Laboratories Overview
11.6.3 United Laboratories Recombinant Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 United Laboratories Recombinant Human Insulin Products and Services
11.6.5 United Laboratories Recombinant Human Insulin SWOT Analysis
11.6.6 United Laboratories Recent Developments
11.7 Dongbro Pharmaceuticri
11.7.1 Dongbro Pharmaceuticri Corporation Information
11.7.2 Dongbro Pharmaceuticri Overview
11.7.3 Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Dongbro Pharmaceuticri Recombinant Human Insulin Products and Services
11.7.5 Dongbro Pharmaceuticri Recombinant Human Insulin SWOT Analysis
11.7.6 Dongbro Pharmaceuticri Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Recombinant Human Insulin Value Chain Analysis
12.2 Recombinant Human Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Insulin Production Mode & Process
12.4 Recombinant Human Insulin Sales and Marketing
12.4.1 Recombinant Human Insulin Sales Channels
12.4.2 Recombinant Human Insulin Distributors
12.5 Recombinant Human Insulin Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Recombinant Human Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 3. Global Recombinant Human Insulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 4. Global Recombinant Human Insulin Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 5. Global Recombinant Human Insulin Sales by Region (2017-2022) & (g)
Table 6. Global Recombinant Human Insulin Sales Market Share by Region (2017-2022)
Table 7. Global Recombinant Human Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Recombinant Human Insulin Revenue Market Share by Region (2017-2022)
Table 9. Global Recombinant Human Insulin Sales Forecast by Region (2023-2028) & (g)
Table 10. Global Recombinant Human Insulin Sales Market Share Forecast by Region (2023-2028)
Table 11. Global Recombinant Human Insulin Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 12. Global Recombinant Human Insulin Revenue Market Share Forecast by Region (2023-2028)
Table 13. Top Recombinant Human Insulin Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 14. Recombinant Human Insulin Market Trends
Table 15. Recombinant Human Insulin Market Drivers
Table 16. Recombinant Human Insulin Market Challenges
Table 17. Recombinant Human Insulin Market Restraints
Table 18. Global Recombinant Human Insulin Sales by Manufacturers (2017-2022) & (g)
Table 19. Global Recombinant Human Insulin Sales Share by Manufacturers (2017-2022)
Table 20. Global Recombinant Human Insulin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Ranking of Global Top Recombinant Human Insulin Manufacturers by Revenue (US$ Million) in 2021
Table 22. Recombinant Human Insulin Revenue Share by Manufacturers (2017-2022)
Table 23. Global Recombinant Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Human Insulin as of 2021)
Table 25. Key Manufacturers Recombinant Human Insulin Average Selling Price (ASP) & (2017-2022) & (USD/mg)
Table 26. Key Manufacturers Recombinant Human Insulin Plants/Factories Distribution
Table 27. Key Manufacturers Recombinant Human Insulin Area Served
Table 28. Date of Key Manufacturers Enter into Recombinant Human Insulin Market
Table 29. Key Manufacturers Recombinant Human Insulin Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Recombinant Human Insulin Sales (g) by Type (2017-2022)
Table 32. Global Recombinant Human Insulin Sales Share by Type (2017-2022)
Table 33. Global Recombinant Human Insulin Revenue (US$ Million) Market Share by Type (2017-2022)
Table 34. Global Recombinant Human Insulin Price (g) by Type (2017-2022)
Table 35. Global Recombinant Human Insulin Sales (g) by Type (2023-2028)
Table 36. Global Recombinant Human Insulin Sales Share by Type (2023-2028)
Table 37. Global Recombinant Human Insulin Revenue (US$ Million) Market Share by Type (2023-2028)
Table 38. Global Recombinant Human Insulin Revenue Share by Type (2023-2028)
Table 39. Global Recombinant Human Insulin Price (g) by Type (2023-2028)
Table 40. Global Recombinant Human Insulin Sales (g) by Application (2017-2022)
Table 41. Global Recombinant Human Insulin Sales Share by Application (2017-2022)
Table 42. Global Recombinant Human Insulin Revenue (US$ Million) Market Share by Application (2017-2022)
Table 43. Global Recombinant Human Insulin Price (g) by Application (2017-2022)
Table 44. Global Recombinant Human Insulin Sales (g) by Application (2023-2028)
Table 45. Global Recombinant Human Insulin Sales Share by Application (2023-2028)
Table 46. Global Recombinant Human Insulin Revenue (US$ Million) Market Share by Application (2023-2028)
Table 47. Global Recombinant Human Insulin Revenue Share by Application (2023-2028)
Table 48. Global Recombinant Human Insulin Price (g) by Application (2023-2028)
Table 49. North America Recombinant Human Insulin Sales by Company (2017-2022) & (g)
Table 50. North America Recombinant Human Insulin Sales Market Share by Company (2017-2022)
Table 51. North America Recombinant Human Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 52. North America Recombinant Human Insulin Revenue Market Share by Company (2017-2022)
Table 53. North America Recombinant Human Insulin Sales by Type (2017-2022) & (g)
Table 54. North America Recombinant Human Insulin Sales by Type (2023-2028) & (g)
Table 55. North America Recombinant Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 56. North America Recombinant Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 57. North America Recombinant Human Insulin Sales by Application (2017-2022) & (g)
Table 58. North America Recombinant Human Insulin Sales by Application (2023-2028) & (g)
Table 59. North America Recombinant Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Recombinant Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Recombinant Human Insulin Sales by Country (2017-2022) & (g)
Table 62. North America Recombinant Human Insulin Sales by Country (2023-2028) & (g)
Table 63. North America Recombinant Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Recombinant Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Recombinant Human Insulin Sales by Company (2017-2022) & (g)
Table 66. Europe Recombinant Human Insulin Sales Market Share by Company (2017-2022)
Table 67. Europe Recombinant Human Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 68. Europe Recombinant Human Insulin Revenue Market Share by Company (2017-2022)
Table 69. Europe Recombinant Human Insulin Sales by Type (2017-2022) & (g)
Table 70. Europe Recombinant Human Insulin Sales by Type (2023-2028) & (g)
Table 71. Europe Recombinant Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 72. Europe Recombinant Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 73. Europe Recombinant Human Insulin Sales by Application (2017-2022) & (g)
Table 74. Europe Recombinant Human Insulin Sales by Application (2023-2028) & (g)
Table 75. Europe Recombinant Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Europe Recombinant Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Europe Recombinant Human Insulin Sales by Country (2017-2022) & (g)
Table 78. Europe Recombinant Human Insulin Sales by Country (2023-2028) & (g)
Table 79. Europe Recombinant Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 80. Europe Recombinant Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 81. Asia Pacific Recombinant Human Insulin Sales by Company (2017-2022) & (g)
Table 82. Asia Pacific Recombinant Human Insulin Sales Market Share by Company (2017-2022)
Table 83. Asia Pacific Recombinant Human Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 84. Asia Pacific Recombinant Human Insulin Revenue Market Share by Company (2017-2022)
Table 85. Asia Pacific Recombinant Human Insulin Sales by Type (2017-2022) & (g)
Table 86. Asia Pacific Recombinant Human Insulin Sales by Type (2023-2028) & (g)
Table 87. Asia Pacific Recombinant Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 88. Asia Pacific Recombinant Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 89. Asia Pacific Recombinant Human Insulin Sales by Application (2017-2022) & (g)
Table 90. Asia Pacific Recombinant Human Insulin Sales by Application (2023-2028) & (g)
Table 91. Asia Pacific Recombinant Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 92. Asia Pacific Recombinant Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 93. Asia Pacific Recombinant Human Insulin Sales by Region (2017-2022) & (g)
Table 94. Asia Pacific Recombinant Human Insulin Sales by Region (2023-2028) & (g)
Table 95. Asia Pacific Recombinant Human Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 96. Asia Pacific Recombinant Human Insulin Revenue by Region (2023-2028) & (US$ Million)
Table 97. Latin America Recombinant Human Insulin Sales by Company (2017-2022) & (g)
Table 98. Latin America Recombinant Human Insulin Sales Market Share by Company (2017-2022)
Table 99. Latin America Recombinant Human Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 100. Latin America Recombinant Human Insulin Revenue Market Share by Company (2017-2022)
Table 101. Latin America Recombinant Human Insulin Sales by Type (2017-2022) & (g)
Table 102. Latin America Recombinant Human Insulin Sales by Type (2023-2028) & (g)
Table 103. Latin America Recombinant Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 104. Latin America Recombinant Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 105. Latin America Recombinant Human Insulin Sales by Application (2017-2022) & (g)
Table 106. Latin America Recombinant Human Insulin Sales by Application (2023-2028) & (g)
Table 107. Latin America Recombinant Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 108. Latin America Recombinant Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 109. Latin America Recombinant Human Insulin Sales by Country (2017-2022) & (g)
Table 110. Latin America Recombinant Human Insulin Sales by Country (2023-2028) & (g)
Table 111. Latin America Recombinant Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 112. Latin America Recombinant Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 113. Middle East and Africa Recombinant Human Insulin Sales by Company (2017-2022) & (g)
Table 114. Middle East and Africa Recombinant Human Insulin Sales Market Share by Company (2017-2022)
Table 115. Middle East and Africa Recombinant Human Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 116. Middle East and Africa Recombinant Human Insulin Revenue Market Share by Company (2017-2022)
Table 117. Middle East and Africa Recombinant Human Insulin Sales by Type (2017-2022) & (g)
Table 118. Middle East and Africa Recombinant Human Insulin Sales by Type (2023-2028) & (g)
Table 119. Middle East and Africa Recombinant Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 120. Middle East and Africa Recombinant Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 121. Middle East and Africa Recombinant Human Insulin Sales by Application (2017-2022) & (g)
Table 122. Middle East and Africa Recombinant Human Insulin Sales by Application (2023-2028) & (g)
Table 123. Middle East and Africa Recombinant Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 124. Middle East and Africa Recombinant Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 125. Middle East and Africa Recombinant Human Insulin Sales by Country (2017-2022) & (g)
Table 126. Middle East and Africa Recombinant Human Insulin Sales by Country (2023-2028) & (g)
Table 127. Middle East and Africa Recombinant Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 128. Middle East and Africa Recombinant Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 129. Akron Biotech Corporation Information
Table 130. Akron Biotech Description and Overview
Table 131. Akron Biotech Recombinant Human Insulin Sales (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2017-2022)
Table 132. Akron Biotech Recombinant Human Insulin Product and Services
Table 133. Akron Biotech Recombinant Human Insulin SWOT Analysis
Table 134. Akron Biotech Recent Developments
Table 135. Wockhardt Corporation Information
Table 136. Wockhardt Description and Overview
Table 137. Wockhardt Recombinant Human Insulin Sales (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2017-2022)
Table 138. Wockhardt Recombinant Human Insulin Product and Services
Table 139. Wockhardt Recombinant Human Insulin SWOT Analysis
Table 140. Wockhardt Recent Developments
Table 141. Dance Biopharm Corporation Information
Table 142. Dance Biopharm Description and Overview
Table 143. Dance Biopharm Recombinant Human Insulin Sales (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2017-2022)
Table 144. Dance Biopharm Recombinant Human Insulin Product and Services
Table 145. Dance Biopharm Recombinant Human Insulin SWOT Analysis
Table 146. Dance Biopharm Recent Developments
Table 147. Novo Nordisk Corporation Information
Table 148. Novo Nordisk Description and Overview
Table 149. Novo Nordisk Recombinant Human Insulin Sales (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2017-2022)
Table 150. Novo Nordisk Recombinant Human Insulin Product and Services
Table 151. Novo Nordisk Recombinant Human Insulin SWOT Analysis
Table 152. Novo Nordisk Recent Developments
Table 153. Gan & Lee Corporation Information
Table 154. Gan & Lee Description and Overview
Table 155. Gan & Lee Recombinant Human Insulin Sales (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2017-2022)
Table 156. Gan & Lee Recombinant Human Insulin Product and Services
Table 157. Gan & Lee Recombinant Human Insulin SWOT Analysis
Table 158. Gan & Lee Recent Developments
Table 159. United Laboratories Corporation Information
Table 160. United Laboratories Description and Overview
Table 161. United Laboratories Recombinant Human Insulin Sales (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2017-2022)
Table 162. United Laboratories Recombinant Human Insulin Product and Services
Table 163. United Laboratories Recombinant Human Insulin SWOT Analysis
Table 164. United Laboratories Recent Developments
Table 165. Dongbro Pharmaceuticri Corporation Information
Table 166. Dongbro Pharmaceuticri Description and Overview
Table 167. Dongbro Pharmaceuticri Recombinant Human Insulin Sales (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/mg) and Gross Margin (2017-2022)
Table 168. Dongbro Pharmaceuticri Recombinant Human Insulin Product and Services
Table 169. Dongbro Pharmaceuticri Recombinant Human Insulin SWOT Analysis
Table 170. Dongbro Pharmaceuticri Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Recombinant Human Insulin Distributors List
Table 174. Recombinant Human Insulin Customers List
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Insulin Product Picture
Figure 2. Global Recombinant Human Insulin Sales Market Share by Type in 2021 & 2028
Figure 3. Global Recombinant Human Insulin Sales Market Share by Application in 2021 & 2028
Figure 4. Type 1 Diabetes Mellitus Use Case
Figure 5. Type 2 Diabetes Mellitus Use Case
Figure 6. Recombinant Human Insulin Report Years Considered
Figure 7. Global Recombinant Human Insulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 8. Global Recombinant Human Insulin Market Size 2017-2028 (US$ Million)
Figure 9. Global Recombinant Human Insulin Sales (2017-2022) & (g)
Figure 10. Global Recombinant Human Insulin Market Size Market Share by Region: 2021 VS 2028
Figure 11. Global Recombinant Human Insulin Sales Market Share by Region (2017-2022)
Figure 12. Global Recombinant Human Insulin Sales Market Share by Region in 2021
Figure 13. Global Recombinant Human Insulin Revenue Market Share by Region in 2017 VS 2021
Figure 14. Global Recombinant Human Insulin Sales Share by Manufacturers in 2021
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Human Insulin Sales in 2021
Figure 16. Recombinant Human Insulin Revenue Share by Manufacturers in 2021
Figure 17. Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Recombinant Human Insulin Revenue Share by Type (2017-2022)
Figure 19. Global Recombinant Human Insulin Revenue Growth Rate by Type in 2017 & 2021
Figure 20. Global Recombinant Human Insulin Revenue Share by Application (2017-2022)
Figure 21. Global Recombinant Human Insulin Revenue Growth Rate by Application in 2017 & 2021
Figure 22. North America Recombinant Human Insulin Sales Market Share by Type (2017-2028)
Figure 23. North America Recombinant Human Insulin Revenue Market Share by Type (2017-2028)
Figure 24. North America Recombinant Human Insulin Sales Market Share by Application (2017-2028)
Figure 25. North America Recombinant Human Insulin Revenue Market Share by Application (2017-2028)
Figure 26. North America Recombinant Human Insulin Sales Share by Country (2017-2028)
Figure 27. North America Recombinant Human Insulin Revenue Share by Country (2017-2028)
Figure 28. U.S. Recombinant Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 29. Canada Recombinant Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 30. Europe Recombinant Human Insulin Sales Market Share by Type (2017-2028)
Figure 31. Europe Recombinant Human Insulin Revenue Market Share by Type (2017-2028)
Figure 32. Europe Recombinant Human Insulin Sales Market Share by Application (2017-2028)
Figure 33. Europe Recombinant Human Insulin Revenue Market Share by Application (2017-2028)
Figure 34. Europe Recombinant Human Insulin Sales Share by Country (2017-2028)
Figure 35. Europe Recombinant Human Insulin Revenue Share by Country (2017-2028)
Figure 36. German
  • Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149
    According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......
  • Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......
  • Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154
    According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......
  • Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......
  • Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120
    Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......
  • Next Generation Sequencing - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......
  • Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......
  • Global Genotyping Market Status and Outlook 2023-2028
    Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128
    Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......
  • Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs